Cidara Therapeutics Inc. (CDTX)
NASDAQ: CDTX
· Real-Time Price · USD
101.99
3.49 (3.54%)
At close: Oct 03, 2025, 3:59 PM
104.02
1.99%
After-hours: Oct 03, 2025, 07:26 PM EDT
3.54% (1D)
| Bid | 76.56 |
| Market Cap | 2.59B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -91.32M |
| EPS (ttm) | -7.68 |
| PE Ratio (ttm) | -13.28 |
| Forward PE | -12.69 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 128 |
| Volume | 1,295,500 |
| Avg. Volume (20D) | 728,550 |
| Open | 99.81 |
| Previous Close | 98.50 |
| Day's Range | 98.91 - 106.63 |
| 52-Week Range | 10.14 - 106.63 |
| Beta | 1.34 |
| Ex-Dividend Date | n/a |
About CDTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CDTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CDTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 days ago
+3.54%
Cidara shares are trading higher after the company...
Unlock content with
Pro Subscription
1 week ago
+20.53%
Cidara Therapeutics shares are trading higher after the company announced updates to its planned Phase 3 registrational trial of CD388 following its End-of-Phase 2 meeting with the FDA.
